User contributions
Jump to navigation
Jump to search
- 13:49, 4 June 2023 diff hist +94 m CNS lymphoma →Ifosfamide & Methotrexate {{#subobject:683c6d|Regimen=1}} current
- 13:10, 4 June 2023 diff hist -44 m Myelodysplastic syndrome →Regimen variant #4, 75 mg/m2, 7 days/cycle (uninterrupted) {{#subobject:bad5a2|Variant=1}} current
- 12:41, 4 June 2023 diff hist +3,593 m Breast cancer current
- 03:35, 4 June 2023 diff hist +3,453 Allogeneic HSCT →Busulfan & Cyclophosphamide {{#subobject:83e07a|Regimen=1}} current
- 02:53, 4 June 2023 diff hist +58 m Follicular lymphoma →O-CHOP {{#subobject:a326e|Regimen=1}} current
- 02:48, 4 June 2023 diff hist +1 m HIV-associated lymphoma →R-CDOP {{#subobject:ec091e|Regimen=1}} current
- 12:57, 3 June 2023 diff hist -68 m Rhabdomyosarcoma, pediatric - historical →Low Risk, all lines of therapy current
- 12:49, 3 June 2023 diff hist 0 m Medulloblastoma →Supportive therapy,
- 12:49, 3 June 2023 diff hist -53 m Medulloblastoma →COG ACNS0334 Protocol A
- 12:48, 3 June 2023 diff hist +276 m Medulloblastoma →Head Start III Protocol D2
- 12:37, 3 June 2023 diff hist +1 m Multiple myeloma, relapsed-refractory →Regimen variant #3 {{#subobject:d67tyg|Variant=1}} current
- 02:44, 3 June 2023 diff hist -14 m Bladder cancer →Supportive therapy
- 02:42, 3 June 2023 diff hist -13 m Chronic lymphocytic leukemia →Supportive therapy
- 02:39, 3 June 2023 diff hist -14 m Penile cancer →BMP {{#subobject:ab9e5f|Regimen=1}}
- 02:30, 3 June 2023 diff hist -72 m Acute myeloid leukemia current
- 02:28, 3 June 2023 diff hist +36 m NK- and T-cell lymphoma →Relapsed or refractory
- 17:24, 2 June 2023 diff hist +39 m Non-small cell lung cancer →Cisplatin & Gemcitabine (GC) {{#subobject:21a22f|Regimen=1}}
- 15:39, 2 June 2023 diff hist +443 m Acute myeloid leukemia, pediatric →MACE {{#subobject:5ahc61|Regimen=1}} current
- 15:33, 2 June 2023 diff hist +309 m Chronic myeloid leukemia, pediatric →Imatinib monotherapy {{#subobject:9jug26|Regimen=1}} current
- 15:29, 2 June 2023 diff hist +826 m Colorectal cancer →FULV {{#subobject:e9add2|Regimen=1}}
- 13:26, 2 June 2023 diff hist -6 m Diffuse large B-cell lymphoma →CBV-Mx, then auto HSCT {{#subobject:59bb2c|Regimen=1}}
- 13:25, 2 June 2023 diff hist -191 m Diffuse large B-cell lymphoma →Consolidation after upfront therapy
- 13:25, 2 June 2023 diff hist +1,634 m Autologous HSCT →CBV-Mx {{#subobject:77feb1|Regimen=1}} current
- 13:14, 2 June 2023 diff hist +1,424 m High-grade B-cell lymphoma →Loncastuximab tesirine monotherapy {{#subobject:jgua99|Regimen=1}} current
- 13:14, 2 June 2023 diff hist +78 m Diffuse large B-cell lymphoma →Lisocabtagene maraleucel monotherapy {{#subobject:6e6u14|Regimen=1}}
- 13:13, 2 June 2023 diff hist +140 m Transformed lymphoma →Lisocabtagene maraleucel monotherapy {{#subobject:6e6u14|Regimen=1}} current
- 13:13, 2 June 2023 diff hist +138 m Primary mediastinal B-cell lymphoma →Relapsed or refractory, further lines of therapy current
- 11:30, 2 June 2023 diff hist +1,836 m Cholangiocarcinoma →Cisplatin & Gemcitabine (GC) & Pembrolizumab {{#subobject:pty057|Regimen=1}}
- 11:29, 2 June 2023 diff hist -1,834 m Cholangiocarcinoma →Cisplatin & Gemcitabine (GC) & nab-Paclitaxel {{#subobject:17f9f2|Regimen=1}}
- 11:28, 2 June 2023 diff hist -93 m Cholangiocarcinoma →References
- 11:28, 2 June 2023 diff hist +3,212 Cholangiocarcinoma →Metastatic, first-line therapy
- 02:34, 2 June 2023 diff hist +533 m Rhabdomyosarcoma →VIE {{#subobject:1b4037|Regimen=1}} current
- 18:24, 1 June 2023 diff hist +405 m Warm autoimmune hemolytic anemia current
- 14:50, 1 June 2023 diff hist +428 m Testicular cancer →VIP {{#subobject:de93dc|Regimen=1}}
- 14:20, 1 June 2023 diff hist +43 m Testicular cancer →GIP {{#subobject:118eb4|Regimen=1}}
- 14:20, 1 June 2023 diff hist +316 m Testicular cancer →Regimen {{#subobject:a138e6|Variant=1}}
- 13:46, 1 June 2023 diff hist +488 m Autologous HSCT →V-BEAM {{#subobject:d6ea18|Regimen=1}}
- 13:04, 1 June 2023 diff hist +384 m Autologous HSCT →FEAM {{#subobject:0aac6f|Regimen=1}}
- 12:50, 1 June 2023 diff hist +65 m Glioblastoma current
- 01:48, 1 June 2023 diff hist +427 m Glioblastoma
- 23:39, 31 May 2023 diff hist +3 m Prostate cancer
- 23:38, 31 May 2023 diff hist +293 m Olaparib (Lynparza) →Prostate cancer current
- 21:25, 31 May 2023 diff hist +50 m B-cell lymphoma of mucosa-associated lymphoid tissue
- 21:22, 31 May 2023 diff hist -14 m Acute promyelocytic leukemia →Supportive therapy
- 21:19, 31 May 2023 diff hist +6 m Waldenström macroglobulinemia →Supportive therapy
- 21:19, 31 May 2023 diff hist +52 m Myelodysplastic syndrome →Supportive therapy
- 15:00, 31 May 2023 diff hist +19 m Esophageal adenocarcinoma →Cisplatin & Fluorouracil (CF) {{#subobject:7b88be|Regimen=1}}
- 14:59, 31 May 2023 diff hist +20 m Esophageal adenocarcinoma →Regimen {{#subobject:24u848|Variant=1}}
- 12:09, 31 May 2023 diff hist +40 m Prostate cancer →Radium-223 monotherapy {{#subobject:35 |Regimen=1}}
- 11:14, 31 May 2023 diff hist +1,034 m Ewing sarcoma →VDC/IE {{#subobject:5bcde5|Regimen=1}}